AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 6994771
Drug: Guanfacine 2.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guanfacine 2.0 mg
Trial: 6994771
Drug: Guanfacine 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guanfacine 1.0 mg
Trial: 6994771
Drug: Clonidine 0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine 0.15 mg
Trial: 6994771
Drug: Clonidine 0.30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine 0.30 mg
Trial: 6994771
Drug: Clonidine 0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine 0.15 mg and 0.30 mg
Trial: 31764741
Drug: Intravenous acetaminophen
RxNorm normalized name: Acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous acetaminophen 1 g
Trial: 17244178
Drug: Intensive group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive group cognitive treatment (IGCT)
Trial: 22801833
Drug: Nonsurgical management
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonsurgical management (nasolacrimal duct massage and topical antibiotics as needed) for 6 months
Trial: 22801833
Drug: Nonsurgical management
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonsurgical management (nasolacrimal duct massage and topical antibiotics as needed)
Trial: 17550443
Drug: Intense pulsed
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intense pulsed light (IPL) treatment with a 530- to 750-nm filter
Trial: 10217341
Drug: Oral sustained
RxNorm normalized name: Sustain Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral sustained release morphine (MST)
Trial: 10217341
Drug: Rectal morphine
RxNorm normalized name: morphine Rectal Suppository
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rectal morphine sulfate suppositories (MSR)
Trial: 1346956
Drug: Once daily
RxNorm normalized name: GEL, ONCE DAILY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once daily gentamicin (4 mg/kg/day)
Trial: 1346956
Drug: Twice daily
RxNorm normalized name: CAPSULE, TWICE DAILY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twice daily gentamicin (4 mg/kg/day)
Trial: 1346956
Drug: Both dosage
RxNorm normalized name: osage orange pollen extract
DrugBank: Maclura pomifera pollen (DB10988)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both dosage schedules of gentamicin
Trial: 6465510
Drug: 0.5 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg/kg promethazine i.m. 45 min before histamine infusion + 400 mg cimetidine i.m. 120 min before histamine infusion
Trial: 6465510
Drug: 0.5 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg/kg promethazine i.m. 45 min before histamine infusion
Trial: 27672108
Drug: Copanlisib at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Copanlisib at a maximum tolerated dose (MTD) of 0.8 mg/kg, administered as three weekly intravenous infusions per 28-day cycle.
Trial: 25427070
Drug: Intralesional bleomycin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intralesional bleomycin (1 mg/ml) after paring the hyperkeratotic tissue
Trial: 18945992
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone (20 microg/kg per day)
Trial: 12634581
Drug: Lopinavir/ritonavir 300/75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lopinavir/ritonavir 300/75 mg/m2 twice daily (after initial dosing of 230/57.5 mg/m2 or 300/75 mg/m2)
Trial: 12634581
Drug: Lopinavir/ritonavir 300/75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lopinavir/ritonavir 300/75 mg/m2 twice daily
Trial: 11314239
Drug: Clodronate (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clodronate (100 mg i.m./14 days)
Trial: 11314239
Drug: Inhaled corticosteroid
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled corticosteroid treatment (fluticasone or beclomethasone) without clodronate
Trial: 8070823
Drug: Enalapril 10
RxNorm normalized name: enalapril 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril 10 mg/day plus aspirin and calcium blockers
Trial: 8070823
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment (aspirin and calcium blockers)
Trial: 3554456
Drug: TMP-SMZ (oral)
RxNorm normalized name: sulfamethoxazole / trimethoprim
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TMP-SMZ (oral)
Trial: 3554456
Drug: TMP-SMZ (intravenous)
RxNorm normalized name: sulfamethoxazole / trimethoprim
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TMP-SMZ (intravenous)
Trial: 3554456
Drug: TMP-SMZ in
RxNorm normalized name: sulfamethoxazole / trimethoprim
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TMP-SMZ in combination with aminoglycoside or antipseudomonal penicillin
Trial: 30918100
Drug: Dimethyl fumarate
RxNorm normalized name: Dimethyl Fumarate
DrugBank: Dimethyl fumarate (DB08908)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dimethyl fumarate (DMF) treatment
Trial: 26492541
Drug: CIO (Complete
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CIO (Complete Insulin Orders)
Trial: 22865311
Drug: Percutaneous coronary
RxNorm normalized name: Glebionis coronaria whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Percutaneous coronary intervention (PCI) in smokers with short time to treatment (<3 hours)
Trial: 22865311
Drug: Fibrinolysis in
RxNorm normalized name: Fibrinolysis inhibitor
DrugBank: Aprotinin (DB06692)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fibrinolysis in smokers with short time to treatment (<3 hours)
Trial: 22865311
Drug: Percutaneous coronary
RxNorm normalized name: Glebionis coronaria whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Percutaneous coronary intervention (PCI) in non-smokers with short time to treatment (<3 hours)
Trial: 22865311
Drug: Fibrinolysis in
RxNorm normalized name: Fibrinolysis inhibitor
DrugBank: Aprotinin (DB06692)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fibrinolysis in non-smokers with short time to treatment (<3 hours)
Trial: 22865311
Drug: Percutaneous coronary
RxNorm normalized name: Glebionis coronaria whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Percutaneous coronary intervention (PCI) in patients with >3 hours to treatment
Trial: 22865311
Drug: Fibrinolysis in
RxNorm normalized name: Fibrinolysis inhibitor
DrugBank: Aprotinin (DB06692)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fibrinolysis in patients with >3 hours to treatment
Trial: 15868655
Drug: D-003 5
RxNorm normalized name: 5-HYDROXYTRYPTOPHAN, D-
FDA approved: no
EMA approved: no
PMDA approved: no
Description: D-003 5 mg/day
Trial: 15868655
Drug: D-003 10
RxNorm normalized name: D
DrugBank: Rosomidnar (DB17154)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: D-003 10 mg/day
Trial: 11253161
Drug: Policosanol 5
RxNorm normalized name: policosanol 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Policosanol 5 mg/day
Trial: 12534315
Drug: Policosanol 10
RxNorm normalized name: policosanol 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Policosanol 10 mg/day
Trial: 8929439
Drug: Phentolamine (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phentolamine (1 mg/kg IV over 20 min)
Trial: 21123458
Drug: 550 mg
RxNorm normalized name: xylitol 550 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 550 mg choline/d
Trial: 25160013
Drug: GTE2 (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GTE2 (2 g/d)
Trial: 25160013
Drug: GTE4 (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GTE4 (4 g/d)
Trial: 25160013
Drug: GTE6 (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GTE6 (6 g/d)
Trial: 17261427
Drug: Over-the-counter medications
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Over-the-counter medications
Trial: 17261427
Drug: Drug-related problems
RxNorm normalized name: Psoriasin Problem Skin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug-related problems
Trial: 15517847
Drug: Intramuscular ziprasidone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular ziprasidone
Trial: 11477858
Drug: Shenqi Fuzheng
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shenqi Fuzheng Injection combined with chemotherapy (Group A)
Trial: 11477858
Drug: Chemotherapy (Group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy (Group C)
Trial: 11477858
Drug: Shenqi Fuzheng
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shenqi Fuzheng Injection (Group B)
Trial: 8588267
Drug: Flavoxate treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flavoxate treatment (1,200 mg/day, 400 mg t.i.d. for 12 weeks)
Trial: 2523634
Drug: Chronic enoximone
RxNorm normalized name: enoximone
DrugBank: Enoximone (DB04880)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chronic enoximone therapy (1 and 2 mg/kg)
Trial: 31415883
Drug: Salmonella typhoid
RxNorm normalized name: Typhoid vaccine (salmonella typhi Ty21a)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salmonella typhoid vaccination (0.025 mg; Typhim Vi, Sanofi Pasteur)
Trial: 26183021
Drug: TBCT (Traditional
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TBCT (Traditional Behavioral Couple Therapy)
Trial: 26183021
Drug: IBCT (Integrative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IBCT (Integrative Behavioral Couple Therapy)
Trial: 20642246
Drug: Tapentadol IR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tapentadol IR 50 or 100 mg
Trial: 24353022
Drug: Oxycodone IR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxycodone IR 5 or 10 mg
Trial: 16801461
Drug: Pharmacological therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacological therapy alone (Control)
Trial: 11094583
Drug: oral clonidine
RxNorm normalized name: Clonidine
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: oral clonidine 2 micrograms kg‐1
Trial: 11094583
Drug: oral clonidine
RxNorm normalized name: Clonidine
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: oral clonidine 4 micrograms kg‐1
Trial: 1473445
Drug: Cholesterol-lowering drug,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholesterol-lowering drug, simvastatin
Trial: 6628810
Drug: 8-methoxypsoralen (8-MOP)
RxNorm normalized name: 8-methoxypsoralen
DrugBank: Methoxsalen (DB00553)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 8-methoxypsoralen (8-MOP) at three dose levels
Trial: 31680600
Drug: Subanesthetic ketamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subanesthetic ketamine infusion
Trial: 29642312
Drug: Maltitol oral
RxNorm normalized name: Maltitol
DrugBank: Maltitol (DB16867)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maltitol oral spray
Trial: 25876529
Drug: Lactobacillus reuteri
RxNorm normalized name: Lactobacillus reuteri
DrugBank: Lactobacillus reuteri (DB14224)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactobacillus reuteri (DSM 17938) at a dose of 10^8 colony forming units
Trial: 25876529
Drug: Placebo (identical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (identical formulation without live micro-organisms)
Trial: 20162373
Drug: Cognitive Behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavioral Therapy (CBT), average of ten sessions
Trial: 19597054
Drug: Alcohol intake
RxNorm normalized name: Alcohol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alcohol intake of 5 to 14.9 g/d
Trial: 15878442
Drug: telithromycin 800
RxNorm normalized name: Telithromycin
DrugBank: Telithromycin (DB00976)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: telithromycin 800 mg qd for 7-10 days
Trial: 10102956
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg curcumin
Trial: 12495265
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg curcumin
Trial: 12495265
Drug: 80 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 mg curcumin
Trial: 9802626
Drug: Amoxicillin/clavulanate or
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin/clavulanate or erythromycin for 10 days (control)
Trial: 7706609
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E supplementation (150 mg/day for 1 week, followed by 300 mg/day for 3 weeks)
Trial: 2615456
Drug: Yi‐qi Huo‐xue
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yi‐qi Huo‐xue Injection (YHI)
Trial: 27699890
Drug: Megagen AnyRidge
RxNorm normalized name: benzalkonium chloride Topical Cream [Abridge Cold Sore]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Megagen AnyRidge (AR) implant
Trial: 27699890
Drug: Megagen EZ
RxNorm normalized name: Jock-Eze
DrugBank: Clotrimazole (DB00257)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Megagen EZ Plus Internal (EZ) implant
Trial: 18848434
Drug: Standardized capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standardized capsule of Camellia sinensis (CSC)
Trial: 15723941
Drug: Intratympanic dexamethasone
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intratympanic dexamethasone injections (4-mg/mL solution, 0.5 mL, once per week for 4 weeks)
Trial: 15723941
Drug: Isotonic sodium
RxNorm normalized name: ISOTONIC SODIUM CHLORIDE SOLUTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isotonic sodium chloride (saline) solution (0.5 mL, once per week for 4 weeks)
Trial: 11880081
Drug: 15 mL
RxNorm normalized name: ethanol 0.15 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mL of 1% lidocaine in the lateral and apical periprostatic regions, 5 mL in each point, 10 minutes before the biopsy
Trial: 11880081
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no lidocaine injection)
Trial: 12063831
Drug: Preoperative therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preoperative therapy
Trial: 9667276
Drug: Both preoperative
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both preoperative and postoperative therapy
Trial: 9667276
Drug: Modern radiation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modern radiation treatment techniques
Trial: 22228322
Drug: Treatment for
RxNorm normalized name: Hair Regrowth Treatment For Men
DrugBank: Minoxidil (DB00350)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Treatment for moderate to severe hot flushes
Trial: 15711601
Drug: High dairy
RxNorm normalized name: Beano Dairy Defense
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dairy protein/high-calcium diet (DP, 2400 mg Ca/d)
Trial: 15711601
Drug: High mixed
RxNorm normalized name: Humalog Mix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High mixed protein/moderate calcium diet (MP, 500 mg Ca/d)
Trial: 11801552
Drug: Topical DFMO
RxNorm normalized name: DFMO
DrugBank: Eflornithine (DB06243)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical DFMO
Trial: 10422932
Drug: Bupivacaine 2.5
RxNorm normalized name: Sure-Amp BUPivacaine 2.5 MG/ML Injectable Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 2.5 mg with fentanyl 25 microg
Trial: 10422932
Drug: Bupivacaine 1.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 1.25 mg with fentanyl 25 microg
Trial: 7768495
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg pravastatin day-1 for 3 weeks
Trial: 733132
Drug: Intravenous penicillin
RxNorm normalized name: Penicillin V
DrugBank: Phenoxymethylpenicillin (DB00417)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous penicillin and tetracycline
Trial: 733132
Drug: Intravenous penicillin
RxNorm normalized name: Penicillin V
DrugBank: Phenoxymethylpenicillin (DB00417)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous penicillin and intramuscular tobramycin
Trial: 29462657
Drug: Serlopitant 5
RxNorm normalized name: Serlopitant
DrugBank: Serlopitant (DB12973)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serlopitant 5 mg
Trial: 31523039
Drug: Dexamethasone (12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (12 mg, two intramuscular injections, 24 hours apart)
Trial: 31523039
Drug: Betamethasone (11.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Betamethasone (11.4 mg, two intramuscular injections, 24 hours apart)
Trial: 19192350
Drug: GnRH antagonist
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH antagonist (0.25 mg per day) during endometrial priming with oestradiol (group I, n = 49)
Trial: 19192350
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (group II, n = 49) receiving only endometrial preparation
Trial: 15235686
Drug: Warfarin for
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin for 24 months
Trial: 3034018
Drug: Ramipril 10
RxNorm normalized name: ramipril 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ramipril 10 mg once daily
Trial: 9291556
Drug: Overall treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Overall treatment (including counselling and occlusal adjustment)
Trial: 9291556
Drug: Demand for
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Demand for rescue treatment
Trial: 25893562
Drug: Creatine (CR)
DrugBank: Creatine (DB00148)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Creatine (CR) supplementation at 20 g day(‐1) during cast-immobilization
Trial: 23911535
Drug: Basal Bolus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basal Bolus regimen with glargine once daily and glulisine before meals
Trial: 23911535
Drug: Basal Plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basal Plus regimen with glargine once daily and supplemental doses of glulisine before meals
Trial: 23911535
Drug: Medicine patients
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medicine patients
Trial: 18422590
Drug: Risedronate (RIS)
DrugBank: Risedronic acid (DB00884)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Risedronate (RIS) 35 mg once weekly
Trial: 18422590
Drug: Teriparatide (TPTD)
RxNorm normalized name: Teriparatide
DrugBank: Teriparatide (DB06285)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Teriparatide (TPTD) 20 microg once daily
Trial: 14976882
Drug: Large dosage
RxNorm normalized name: Bos taurus large intestine preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Large dosage of Salvia injection (24 ml)
Trial: 14976882
Drug: Middle dosage
RxNorm normalized name: wheat middlings extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Middle dosage of Salvia injection (16 ml)
Trial: 14976882
Drug: Small dosage
RxNorm normalized name: smallpox vaccine live, New York City Board of Health vaccinia strain Injectable Solution [ACAM2000]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Small dosage of Salvia injection (8 ml)
Trial: 14976882
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no Salvia injection)
Trial: 8835705
Drug: Brofaromine (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brofaromine (150 mg daily)
Trial: 3609849
Drug: D5NS infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: D5NS infusion (Control)
Trial: 25007166
Drug: Heparin-grafted dialyzer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin-grafted dialyzer
Trial: 20235450
Drug: Diplopore puncture
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diplopore puncture of tympanum and intratympanic administration (DPTIA) combined with medication
Trial: 20235450
Drug: Haplopore puncture
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haplopore puncture of tympanum combined with medication
Trial: 18672766
Drug: Modified Wuhua
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modified Wuhua Decoction (WHD) plus oral levocetirizine tablet
Trial: 18672766
Drug: Levocetirizine tablet
RxNorm normalized name: levocetirizine Oral Tablet
DrugBank: Levocetirizine (DB06282)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Levocetirizine tablet alone
Trial: 16096356
Drug: Female workers
RxNorm normalized name: Apis cerana worker secretion preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Female workers in public administration
Trial: 9372530
Drug: quetiapine (300-700
FDA approved: no
EMA approved: no
PMDA approved: no
Description: quetiapine (300-700 mg/day)
Trial: 9372530
Drug: clozapine (300-600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: clozapine (300-600 mg/day)
Trial: 9372530
Drug: haloperidol (10-20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: haloperidol (10-20 mg/day)
Trial: 9382121
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg alendronate
Trial: 12006327
Drug: Alendronate (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alendronate (all doses)
Trial: 24997476
Drug: Standard dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard dose of 25‐30 minutes of aerobic exercise (STAN)
Trial: 24997476
Drug: Higher dose
RxNorm normalized name: BENZOCAINE 50 mg in 1 mL TOPICAL GEL [HIGHER CONTROL Male Climax Control Lubricating]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher dose of 50‐60 minutes of aerobic exercise (HIGH)
Trial: 24997476
Drug: Higher dose
RxNorm normalized name: BENZOCAINE 50 mg in 1 mL TOPICAL GEL [HIGHER CONTROL Male Climax Control Lubricating]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher dose of 50‐60 minutes of combined aerobic and resistance exercise (COMB)